Endothelial barrier disorder in hereditary angioedema: molecular mechanisms and therapeutic implications

• by Nan Zhou, Jianqiang Wu, Yuxiang Zhi

• June 1, 2026

Hospitalists Are Already Using AI—Why Implementation Will Determine Its Impact

• by Anna Maw, Aakriti Pandita, Marisha Burden

• June 1, 2026

FDA Expands Guselkumab Label in PsA

Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.

• by Kathryn Wighton

• May 29, 2026

• 2 min

Prompt and Intensive Antiviral Chemoprophylaxis in Nursing Home Influenza Outbreaks

• by Joe B. B. Silva, Han-Chih T. Hsieh, Chanelle J. Howe, Stefan Gravenstein, Laura A. Reich, Andrew R. Zullo

• June 1, 2026